| Autor: |
Ferrer, Christina M., Cho, Hyo Min, Boon, Ruben, Bernasocchi, Tiziano, Wong, Lai Ping, Cetinbas, Murat, Haggerty, Elizabeth R., Mitsiades, Irene, Wojtkiewicz, Gregory R., McLoughlin, Daniel E., Aboushousha, Reem, Abdelhamid, Hend, Kugel, Sita, Rheinbay, Esther, Sadreyev, Ruslan, Juric, Dejan, Janssen-Heininger, Yvonne M. W., Mostoslavsky, Raul |
| Zdroj: |
Nature Cell Biology; June 2024, Vol. 26 Issue: 6 p975-990, 16p |
| Abstrakt: |
Identifying the adaptive mechanisms of metastatic cancer cells remains an elusive question in the treatment of metastatic disease, particularly in pancreatic cancer (pancreatic adenocarcinoma, PDA). A loss-of-function shRNA targeted screen in metastatic-derived cells identified Gstt1, a member of the glutathione S-transferase superfamily, as uniquely required for dissemination and metastasis, but dispensable for primary tumour growth. Gstt1is expressed in latent disseminated tumour cells (DTCs), is retained within a subpopulation of slow-cycling cells within existing metastases, and its inhibition leads to complete regression of macrometastatic tumours. This distinct Gstt1highpopulation is highly metastatic and retains slow-cycling phenotypes, epithelial–mesenchymal transition features and DTC characteristics compared to the Gstt1lowpopulation. Mechanistic studies indicate that in this subset of cancer cells, Gstt1 maintains metastases by binding and glutathione-modifying intracellular fibronectin, in turn promoting its secretion and deposition into the metastatic microenvironment. We identified Gstt1 as a mediator of metastasis, highlighting the importance of heterogeneity and its influence on the metastatic tumour microenvironment. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Full text from SpringerLink